TCL Archive On Capitol Hill: Funding Outlook Brighter For NIH and NCI as appropriators Provide Increases October 1, 1999
TCL Archive Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival December 27, 2013
TCL Archive In Brief: NCI Claim “Major Finding” In Treatment Of Soft Tissue Sarcoma With Three Modalities; 93% Survival October 9, 1981
TCL Archive Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL July 11, 2014
